StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Verbindung

Zucapsaicin

HCID 1548942
Neue NotizNeue ReaktionAnfrage stellen
Druckvorschau

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
25775-90-0
Standard-SMILES
COc1cc(CNC(=O)CCCC/C=C\C(C)C)ccc1O
InChIKey
YKPUWZUDDOIDPM-VURMDHGXSA-N
Summenformel
C18H27NO3
Durchschnittliche Molmasse
305,4 g/mol
Monoisotopische Masse
305,19909372

Überblick

Zucapsaicin is a member of phenols and a member of methoxybenzenes.

Namen und Bezeichner

Bevorzugter Name
Zucapsaicin
IUPAC
(Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
Englischer Name
(Z)-CAPSAICIN
Summenformel
C18H27NO3
Molmasse
305.41

Namen und Synonyme

Zucapsaicincis-Capsaicin25775-90-0CivamideCivanexZucapsaicinaZucapsaicine(Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide15OX67P3846-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (Z)-DTXSID101014453zucapsaicinum
Weitere Namen anzeigen
cis-Capsaicine(z)-6-nonenamidD3-cis-CapsaicinZucapsaicin,civaMideCivamide cis-CapsaicinCivamide (Zucapsaicin)
(Z)-N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methylnon-6-enamideRefChem:905400DTXCID90911474M02AB02(Z)-Capsaicin(Z)-N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide(Z)-8-Methyl-N-vanillyl-6-nonenamideMFCD00209942

Datenbank-Bezeichner

CAS
25775-90-0
PubChem CID
1548942
DTXSID
DTXSID101014453
ChEMBL
CHEMBL313971
ChEBI
CHEBI:135952
UNII
15OX67P384
EC Number
636-760-0
Nikkaji
J74.699A

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
3,6
Polarare Oberfläche (TPSA)
58,6 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
9
Schwere Atome
22
Formalladung
0
Komplexität
341

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
SolubilityInsoluble
Melting Point71.5-74.5

Physikochemische Eigenschaften

Schmelzpunkt
70 °C · 70 °C
Siedepunkt
511.5 · 511.5±50.0 °C(Predicted)
Dichte
1.041 · 1.041±0.06 g/cm3(Predicted)
storage temp.
2 · 2-8°C
Löslichkeit
Chloroform (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
9.76 · 9.76±0.20(Predicted)
Farbe
White to Off-White
Stabilität
Light Sensitive
InChI
InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6-

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P233, P260, P261, P264, P264+P265, P270, P271, P272, P280, P284, P301+P316, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P333+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationChemical: 6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (Z)-
Hazard Classes and CategoriesAcute Tox. 3 (100%)

Sicherheitsdaten

Toxizität
LD50 intraperitoneal in mouse: 25mg/kg

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

M - Musculo-skeletal system

QM - Musculo-skeletal system

Pharmacodynamics · 1 Eintrag

Zucapsaicin mediates an antinociceptive action via acting as an agonist at TRPV1. TRPV1 play an important physiological role of transducing chemical, mechanical and thermal stimuli as well as pain transduction, and participate in pain modulation and perception. They are mainly distributed in C sensory nerve fibers as well as Aẟ fibers to transmit sensory information involving inflammatory and neuropathic pain, and activation of these channels releasesomatostatin, calcitonin gene-related peptide (CGRP) and other neuropeptides (neurokinin A, kassinin), leading to neurogenic inflammation. Zucapsaicin is also reported to affect the peptidergic afferent neurons via a desensitization mechanism to decrease the levels of dorsal root ganglia and sciatic calcitonin gene-related peptide (CGRP) and substance P (SP).

Mechanism of Action · 1 Eintrag

Zucapsaicin excites and desensitizes C-fibers via agonist at TRPV1 on nociceptive neurons. It binds to intracellular sites and initially stimulates the channels, causing burning sensation. Activation of TRPV1 results in calcium influx and sodium, which leads to cell depolarization. Hypersensitization by zucapsaicin is then followed by reduced sensitivity and persistent desensitization (tachyphylaxis) of the channels via various pathways. Densentiziation is thought to be dependent on intraceullar levels of calcium. Decreased TRPV1 channel action and release of inflammatory neuropeptides induces an analgesic effect, and pain relief. Zucapsaicin activates calcineurin and calcium-dependent protein kinase C isoforms which results in phosphorylation of TRPV1. Phosphorylation of TRPV1 enhances reponsivity to zucapsaicin by potentiating capsaicin- or proton-evoked responses and reducing the temperature threshold for TRPV1 activation. Studies suggest that zucapsaicin is involved in activation of phospholipase C with the subsequent phosphatidylinositol 4,5-biphosphate (PIP2) hydrolysis, which results in TRPV1 inactivation. Tachyphylaxis or persistent desensitization is reversible, and involves the downregulation of proalgesic substances (such as SP) and upregulation of analgesic peptides.

Biological Half-LifeIn rats, the elimination half life of zucapsaicin and its metabolites is approximately 7 to 11 hours.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen

Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Weitere Aktionen
Neue NotizNeue ReaktionAnfrage stellen
InChIKey
YKPUWZUDDOIDPM-VURMDHGXSA-N
SMILES
C(NCC1=CC=C(O)C(OC)=C1)(=O)CCCC/C=C\C(C)C
Metabolism/MetabolitesIn vitro studies demonstrates weak to moderate inhibitiory effects on various cytochrome P450 enzymes, although not clinically significant due to low systemic absorption.
Absorption, Distribution and Excretion · 2 Einträge

Zucapsaicin displays low systemic absorption and localizes at the area of application. In animal studies, systemic absorption is 0.075%.

In rat studies, zucapsaicin and its metabolites are slowly excreted into urine and feces (up to 2/3), with minimal elimination via exhalation following dermal administration.

Anwendungen · 2 Einträge

BeschreibungZucapsaicin is a topical analgesic that was approved in Canada in July 2010 for use in conjunction with oral COX-2 inhibitors or NSAIDs to relieve severe pain in adults with osteoarthritis of the knee. Zucapsaicin is the cis-isomer of the natural product capsaicin. Capsaicin is available without a prescription in creams, lotions, and patches for the treatment of neuropathic and musculoskeletal pain. Zucapsaicin is available as a 0.075% by weight cream. The advantages of zucapsaicin compared with capsaicin are reported to be a lesser degree of local irritation (stinging, burning, erythema) in patients and a greater degree of efficacy in preclinical animal models of pain. The analgesic action of zucapsaicin and capsaicin is mediated through the transient receptor potential vanilloid type 1 (TRPV1) channel.

Verwenden(Z)-CAPSAICIN is used as a tool in neurobiological research. Prototype vanilloid receptor agonist.